Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Theranostics

<< Previous

Bullboard Posts

Next >>

Comment by Bucknelly21on Jul 26, 2021 3:52pm

124 Views

Post# 33605532

RE:RE:RE:Theranostics

scarlet1967 wrote: I am starting to think your skepticism lies every where in case of THTX, I believe if they can convince you, they can convince anyone. Maybe they should start having practice sessions with you first before trying to strike deals or promote their programs:)....

qwerty22 wrote:
It's a perfect example. Looks like this spun out of Case Western bioengineering department, think of Cleveland Clinic if you want references. This guy is the brains behind it.

https://engineering.case.edu/profiles/zxl125

He's been publishing for 20 years on the subject. Everything says this is a company with deep roots in the subject. No doubt surrounded by all the necessary infrastructure. For me it's not a tech you pull out of a hat when you are renting a couple of lab benches in UQAM. That's not intended to be derogatory towards thtx just a likely description of their reality.

I'm not against the idea that it would be a useful tool but is it at all practical to expect thtx to move into this space given their history and circumstances? That's where my scepticism lies.

Lee430 wrote: Molecular-targeted liquid radiation, is this simular to what jfm1330 has been refering to that Thera could use with the peptide or a completly different new therapy?

https://www.dailybulletin.com/2021/07/24/new-hope-in-the-fight-against-prostate-cancer-we-can-win-this-war/